
The Femtech World Awards celebrates the very best of female-led and focused health innovation, spanning menstrual health, menopause, cardiovascular health and beyond.
This year, we are once again set to recognise the scientists, clinicians and innovators developing evidence-based solutions that have the power to improve millions of lives.
The Research Project of the Year award recognises an outstanding research project that is advancing knowledge, innovation and impact in women’s health.
The winning project will have demonstrated excellence in scientific rigor, originality and potential to transform understanding, diagnosis or treatment of health issues affecting women.
This award recognises projects that are shaping the future of evidence-based care and creating pathways to better health outcomes for women.
The Research Project of the Year award is sponsored by OncoGenomX.
OncogenomX is dedicated to offering solutions and providing comprehensive support services that empower Drug Developers, Clinical Researchers, Oncologists, NextGenSeq Diagnostics Laboratories, NextGenSeq Service Organisations, Cancer Diagnostics and Therapeutics Companies to achieve their ambitious goals.
With a team of experienced professionals, OncoGenomX offers tailor-made solutions to help you navigate the complexities in your field of interest along the cancer care value chain with confidence.
Wolfgang Hackl, CEO at OncoGenomX, said: “At OncoGenomX, we’re proud to sponsor the FemTech World Research Award because we believe in recognizing the trailblazers who are redefining women’s health.
“Championing female-led innovation isn’t just about equity – it’s about unlocking smarter, more inclusive solutions that benefit everyone.
“This award celebrates the bold ideas and brilliant minds shaping the future of healthcare.”
The Femtech World Awards are free to enter, with winners and shortlisted entries receiving extensive coverage across all Femtech World platforms.
Winners will also receive a trophy and interview.
Find out more about the awards and enter here.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.






